- Product Details
Keywords
- 368-16-1
- 3-METHYL-L-HISTIDINE N-HYDRATE
- C7H13N3O3
Quick Details
- ProName: Newblue-CHEM 368-16-1 3-METHYL-L-HIS...
- CasNo: 368-16-1
- Molecular Formula: C7H13N3O3
- Appearance: conform
- Application: 368-16-1
- DeliveryTime: within 7 days after PO
- PackAge: normal package
- Port: any port in china
- ProductionCapacity: 1 Metric Ton/Day
- Purity: 99%min
- Storage: conform
- Transportation: by air
- LimitNum: 1 Kilogram
- Grade: Industrial Grade,Food Grade,Pharma Gra...
Superiority
Our company was built in 2009 with an ISO certificate.In the past 5 years, we have grown up as a famous fine chemicals supplier in China and we had established stable business relationships with Samsung,LG,Merck,Thermo Fisher Scientific and so on.Our main business covers the fields below:
1.Noble Metal Catalysts (Pt.Pd...)
2.Organic Phosphine Ligands (Tert-butyl-phosphine.Cyclohexyl-phosphine...)
3.OLED intermediates (Fluorene,Carbazole,Boric acid...)
4.Customs Synthesis
Our advantage:
1. Higest quality and good package
2.Fast delivery
3.Better payment term
4.Fast response to customer within 6 hours
5.Good business credit in Europe ,US ,Japan ,Korea
Anyway ,if you need any chemicals from China ,Henan Newblue can help you
Details
3-METHYL-L-HISTIDINE N-HYDRATE Basic information |
Product Name: | 3-METHYL-L-HISTIDINE N-HYDRATE |
Synonyms: | 3-methylhistidine;3-METHYL-L-HISTIDINE N-HYDRATE;π-methyl-l-histidine;(2S)-2-amino-3-(3-methylimidazol-4-yl)propanoic acid;METHYL-L-HISTIDINE, 1-(RG);METHYL-L-HISTIDINE, 3-(RG);1-METHYL-L-HISTIDINE CRYSTALLINE;H-His(p-Me)-OH |
CAS: | 368-16-1 |
MF: | C7H13N3O3 |
MW: | 187.2 |
EINECS: | 206-704-6 |
Product Categories: | Amino Acids;Chiral Compound;amino acid |
Mol File: | 368-16-1.mol |
3-METHYL-L-HISTIDINE N-HYDRATE Chemical Properties |
density | 1.37 |
storage temp. | Store at RT. |
CAS DataBase Reference | 368-16-1(CAS DataBase Reference) |
3-METHYL-L-HISTIDINE N-HYDRATE Usage And Synthesis |
Usage | 3-N-Methyl-L-histidine is a potential compound to be used as a treatment with pharmacological PPARα agonists to stimulate the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeleta l muscle of rodents. |